| Literature DB >> 30450375 |
Dennis F Lovelock1, Terrence Deak1.
Abstract
Acute and chronic stress challenges have a profound influence on the development and expression of subsequent affective disorders, alcohol use disorders, and natural aging processes. These experiments examined adaptation in neuroimmune and neuroendocrine responses that occurred as a result of exposure to a novel model of chronic stress, termed chronic escalating distress (CED). This model involves exposure to highly predictable daily stress challenges involving a systematic escalation in both the intensity and length of daily stress challenges, and has recently been shown to profoundly alter alcohol sensitivity. Male Sprague-Dawley rats were exposed to an 11 day procedure where days 1-5 consisted of 60 min of restraint, days 6-10 consisted of 60 min of restraint immediately followed by 30 min of forced swim, and on day 11 subjects were exposed to a 2 h session of intermittent footshock. Experiment 1 examined adaptation in the corticosterone (CORT) response at key points in the 11 day procedure, and found that the escalation in stressors disrupted habituation to restraint, whereas the CORT response to daily forced swim exposure increased across days. Experiment 2 investigated the impact of this stress paradigm on the expression of several cytokine (IL-1β, IL-6, TNF-α) and cellular activation marker (c-Fos, CD14, CD200R) genes in key brain regions (PVN, HPC, & PFC) known to be influenced by stress. Interestingly, a history of CED had no effect on footshock-induced neuroimmune changes (increased IL-1 in the PVN; increased IL-6 in the HPC and PFC). In addition, acute footshock and CED produced similar c-fos induction within the PVN whereas CED led to enhanced c-fos induction in both the HPC and PFC. These findings support recent work indicating that neuroimmune responses to acute stress challenges persisted in rats with a recent history of repeated stress exposure, and that these effects occurred contemporaneously with ongoing changes in HPA axis reactivity. Overall, this CED model may serve as a highly tractable model for studying adaptation to chronic stress, and may have implications for understanding stress-induced alterations in alcohol sensitivity and natural aging processes.Entities:
Keywords: Corticosterone; Cytokine; Escalating stress; Habituation; Interleukin-1; Neuroimmune; Sequential stress
Year: 2018 PMID: 30450375 PMCID: PMC6234279 DOI: 10.1016/j.ynstr.2018.08.007
Source DB: PubMed Journal: Neurobiol Stress ISSN: 2352-2895
Fig. 1A. Rats (n = 8 per group) were exposed to 10 total days of stress (5 days of restraint then 5 days of restraint followed immediately by forced swim) or were kept in their homecages for 10 days. All rats were then exposed to 2 h of footshock on the 11th day. Red dots depict the points at which tail blood samples were collected and blue triangles indicate points when body weights were measured. B. Body weight data. For days 0, 6, and 10, * indicate main effect of day. On day 11, # indicates a main effect of stress. C. CORT levels across the experiment. * represents a significant difference from that day's baseline within group and day, the # represents a difference between the two conditions at that specific day and timepoint, and different letters indicate significant differences in the CED condition at the 60 and 90 min timepoints. (1) highlights the expected habituation of the CORT response to restraint, (2) identifies an increase in the CORT response possibly due to the anticipation of forced swim following restraint, and (3) highlights a possible sensitization effect of forced swim. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
Fig. 2Experiment 2 design, body weight data, and CORT data (n = 8/group). A. Rats were exposed to 10 days of stress (restraint for 5 days then 5 days of restraint immediately followed by forced swim) or remained in the homecage, then on the 11th day were exposed to 2 h footshock or were kept in the homecage. B. Body weight gain across days. C. Body weight gain from baseline to the final day of Experiment 2. D. Peripheral CORT measures after footshock on the 11th day of testing. Different letters indicate significant differences.
Real-time RT-PCR results from Experiment 2.
| Non-stressed Control | Stress History Only | Footshock Only | Chronic Escalating Distress | Scrambled | Statistical analyses | |
|---|---|---|---|---|---|---|
| β-actin | 101.8 ± 7.8 | 114.9 ± 6.0 | 101.2 ± 10.2 | 87.75 ± 4.7 | 92.4 ± 7.1 | F (4,34) = .2.04 p > 0.05 |
| c-Fos | F (4,34) = 86.30, p < 0.001 | |||||
| TNF-α | 101.0 ± 5.7 | 82.0 ± 4.0 | 72.0 ± 6.0 | 78.6 ± 12.9 | 75.7 ± 7.7 | F (4,34) = 1.87, p > 0.05 |
| IL-1β | F (4,34) = 5.47, p < 0.01 | |||||
| IL-6 | 102.8 ± 9.3 | 131.5 ± 7.2 | 135.22 ± 15.5 | 88.9 ± 13.7 | 120.0 ± 18.3 | F (4,33) = 2.01, p > 0.05 |
| CD14 | F (4,34) = 11.72, p < 0.001 | |||||
| CD200 | 100.6 ± 4.8 | 103.0 ± 5.2 | 97.1 ± 3.6 | 117.7 ± 7.6 | 100.3 ± 4.1 | F (4,34) = 2.39, p > 0.05 |
| CD200R | 105.0 ± 12.7 | 76.1 ± 8.9 | 87.1 ± 11.6 | 121.9 ± 14.8 | 88.3 ± 11.5 | F (4,34) = 2.25, p > 0.05 |
| GFAP | 106.3 ± 14.0 | 84.8 ± 9.4 | 126.1 ± 11.6 | 119.6 ± 6.2 | 123.4 ± 12.5 | F (4,34) = 2.48, p > 0.05 |
| CHI3l3 | 122.3 ± 30.3 | 130.9 ± 16.2 | 160.8 ± 32.8 | 169.2 ± 24.8 | 188.6 ± 33.4 | F (4,34) = 0.93, p > 0.05 |
| β-actin | 126.6 ± 30.1 | 160.68 ± 22.3 | 155.9 ± 16.4 | 102.7 ± 20.3 | 153.8 ± 16.3 | F (4,35) = 1.30, p > 0.05 |
| c-Fos | F (4,35) = 8.01, p < 0.001 | |||||
| TNF-α | F (4,35) = 12.83, p > 0.001 | |||||
| IL-1β | F (4,35) = 3.25 p > 0.05 | |||||
| IL-6 | F (4,35) = 7.45, p < 0.001 | |||||
| CD14 | 101.0 ± 5.2 | 88.9 ± 10.2 | 55.1 ± 6.4 | 105.5 ± 14.6 | 101.1 ± 24.5 | F (4,35) = 1.19, p > 0.05 |
| CD200 | 111.4 ± 18.0 | 82.0 ± 7.9 | 82.4 ± 6.7 | 105.0 ± 14.3 | 95.6 ± 9.8 | F (4,35) = 1.87, p > 0.05 |
| CD200R | 108.4 ± 15.2 | 109.7 ± 11.0 | 90.2 ± 16.2 | 218.7 ± 78.1 | 137.7 ± 14.2 | F (4,35) = 0.20, p > 0.05 |
| GFAP | 104.3 ± 11.3 | 89.5 ± 5.4 | 99.7 ± 19.0 | 93.3 ± 11.4 | 94.7 ± 13.0 | F (4,35) = 0.44, p < 0.05 |
| CHI3l3 | 104.0 ± 12.2 | 88.2 ± 9.5 | 86.9 ± 9.6 | 93.8 ± 11.1 | 97.9 ± 10.4 | F (4,35) = 0.91 p > 0.05 |
| β-actin | 103.4 ± 9.1 | 93.1 ± 14.0 | 108.2 ± 12.3 | 107.3 ± 7.9 | 115.7 ± 9.7 | F (4,34) = 0.58, p > 0.05 |
| c-Fos | F (4,33) = 121.87, p < 0.001 | |||||
| TNF-α | F (4,31) = 22.60, p < 0.001 | |||||
| IL-1β | 114.1 ± 20.1 | 137.2 ± 31.3 | 141.7 ± 25.9 | 96.3 ± 27.1 | 88.0 ± 11.3 | F (4,33) = 0.77, p > 0.05 |
| IL-6 | F (4,32) = 2.80, p < 0.05 | |||||
| CD14 | 108.1 ± 17.7 | 117.5 ± 8.3 | 96.8 ± 10.7 | 111.4 ± 27.1 | 107.2 ± 10.7 | F (4,32) = 0.25, p > 0.05 |
| CD200 | 226.4 ± 38.6 | 229.2 ± 29.8 | 200.8 ± 14.7 | 256.0 ± 34.9 | 214.8 ± 17.0 | F (4,32) = 0.49, p > 0.05 |
| CD200R | 139.6 ± 30.9 | 143.8 ± 7.8 | 162.3 ± 22.8 | 182.9 ± 20.3 | 141.4 ± 20.2 | F (4,32) = 0.61, p > 0.05 |
| GFAP | 108.6 ± 17.8 | 104.9 ± 13.3 | 111.6 ± 10.5 | 84.7 ± 12.1 | 82.3 ± 13.9 | F (4,32) = 0.98, p > 0.05 |
| CHI3l3 | 113.3 ± 18.7 | 85.1 ± 7.5 | 100.7 ± 18.7 | 89.0 ± 8.8 | 101.5 ± 20.4 | F (4,32) = 0.50, p > 0.05 |
Note. Means and SEM for Experiment 2. Gene expression data in the paraventricular nucleus of the hypothalamus (PVN), prefrontal cortex (PFC), and hippocampus (HPC) adjusted to β-actin as housekeeper and expressed as percent change from the control group (homecage). Bold text indicates a significant effect; data points marked with differing letters are significantly different from one another (p < 0.05).
Fig. 3Inflammatory cytokine and c-Fos real-time RTPCR results from Experiment 2. All data is expressed relative to the control group (homecage) and normalized to β-actin. Each group consisted of 6–8 subjects. Different letters indicate significant differences. A–C: IL-1β; D–F: IL-6; G–I: TNF-α; J–L: c-Fos.